Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis

Abstract

A total of 118 consecutive renal transplant recipients were followed prospectively. Multivariate logistic stepwise regression was used to estimate the effect of CMV viremia and other covariates on subclinical rejection and/or IF/TA.

Keywords

• Effect
• cytomegalovirus
• viremia
• subclinical
• rejection
• interstitial
• fibrosis
• tubular
• atrophy
• protocol
• biopsy
• months
• renal
• allograft
• recipients
• managed
• preemptive
• therapy
• antiviral
• prophylaxis